» Articles » PMID: 33974637

Inappropriate Antibiotic Use in the COVID-19 Era: Factors Associated with Inappropriate Prescribing and Secondary Complications. Analysis of the Registry SEMI-COVID

Abstract

Background: Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to increased complications, including antibacterial resistance. We aim to analyze risk factors for inappropriate antibiotic prescription in these patients and describe possible complications arising from their use.

Methods: The SEMI-COVID-19 Registry is a multicenter, retrospective patient cohort. Patients with antibiotic were divided into two groups according to appropriate or inappropriate prescription, depending on whether the patient fulfill any criteria for its use. Comparison was made by means of multilevel logistic regression analysis. Possible complications of antibiotic use were also identified.

Results: Out of 13,932 patients, 3047 (21.6%) were prescribed no antibiotics, 6116 (43.9%) were appropriately prescribed antibiotics, and 4769 (34.2%) were inappropriately prescribed antibiotics. The following were independent factors of inappropriate prescription: February-March 2020 admission (OR 1.54, 95%CI 1.18-2.00), age (OR 0.98, 95%CI 0.97-0.99), absence of comorbidity (OR 1.43, 95%CI 1.05-1.94), dry cough (OR 2.51, 95%CI 1.94-3.26), fever (OR 1.33, 95%CI 1.13-1.56), dyspnea (OR 1.31, 95%CI 1.04-1.69), flu-like symptoms (OR 2.70, 95%CI 1.75-4.17), and elevated C-reactive protein levels (OR 1.01 for each mg/L increase, 95% CI 1.00-1.01). Adverse drug reactions were more frequent in patients who received ANTIBIOTIC (4.9% vs 2.7%, p < .001).

Conclusion: The inappropriate use of antibiotics was very frequent in COVID-19 patients and entailed an increased risk of adverse reactions. It is crucial to define criteria for their use in these patients. Knowledge of the factors associated with inappropriate prescribing can be helpful.

Citing Articles

The impact of health and technology shifts on antibiotic use among the elderly in Thailand.

Prasit N, Phimha S, Nonthamat A, Nilnate N, Nidthumsakul N, Sresutham P Sci Rep. 2025; 15(1):6220.

PMID: 39979356 PMC: 11842735. DOI: 10.1038/s41598-025-89040-x.


To prescribe or not: a two-center retrospective observational study of antibiotics usage and outcomes of COVID-19 in Turkey.

Karakoc H, Aydin M, Ozcan S, Olcar Y, Sumlu E, Dindar E Sci Rep. 2024; 14(1):21031.

PMID: 39251674 PMC: 11384660. DOI: 10.1038/s41598-024-72086-8.


Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic.

Opalska A, Gardarsdottir H, Kwa M, Wojkowska-Mach J, Sabate M, Ballarin M Eur J Clin Pharmacol. 2024; 80(10):1581-1589.

PMID: 39017693 PMC: 11393094. DOI: 10.1007/s00228-024-03726-1.


Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models.

Zhong X, Palin V, Ashcroft D, Goldacre B, Mackenna B, Mehrkar A BMC Med. 2024; 22(1):277.

PMID: 38956603 PMC: 11220965. DOI: 10.1186/s12916-024-03480-2.


The Trend of Antibiotic Consumption After the COVID-19 Pandemic: Approach to Future Outbreaks.

Elsafi S, Almutairi S, Alsulaimani M, AlBahrani S, Al-Maqati T, Alanazi W Infect Drug Resist. 2024; 17:2227-2236.

PMID: 38854778 PMC: 11162212. DOI: 10.2147/IDR.S460148.


References
1.
Vaughn V, Gandhi T, Petty L, Patel P, Prescott H, Malani A . Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clin Infect Dis. 2020; 72(10):e533-e541. PMC: 7499526. DOI: 10.1093/cid/ciaa1239. View

2.
Spigaglia P . COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients. Anaerobe. 2020; 64:102233. PMC: 7315154. DOI: 10.1016/j.anaerobe.2020.102233. View

3.
Cheng K, He M, Shu Q, Wu M, Chen C, Xue Y . Analysis of the Risk Factors for Nosocomial Bacterial Infection in Patients with COVID-19 in a Tertiary Hospital. Risk Manag Healthc Policy. 2020; 13:2593-2599. PMC: 7671853. DOI: 10.2147/RMHP.S277963. View

4.
Casas-Rojo J, Anton-Santos J, Millan-Nunez-Cortes J, Lumbreras-Bermejo C, Ramos-Rincon J, Roy-Vallejo E . [Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry]. Rev Clin Esp. 2021; 220(8):480-494. PMC: 7368900. DOI: 10.1016/j.rce.2020.07.003. View

5.
Gautret P, Lagier J, Parola P, Hoang V, Meddeb L, Sevestre J . Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020; 34:101663. PMC: 7151271. DOI: 10.1016/j.tmaid.2020.101663. View